Hutchmed China Ltd ADR (HCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HCM | AMGN | VRTX | BMY | GILD |
| Company | Hutchmed China Ltd ADR | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 16.84 | 276.40 | 463.68 | 56.60 | 88.03 |
| High | 16.89 | 276.40 | 463.68 | 56.60 | 88.03 |
| Low | 16.63 | 276.40 | 463.68 | 56.60 | 88.03 |
| Last | 16.83 | 277.23 | 460.23 | 56.19 | 86.83 |
| Change | +0.09 | -1.53 | -6.78 | -0.61 | -1.63 |
| % Change | +0.54% | -0.55% | -1.45% | -1.07% | -1.84% |
| Volume | 37,900 | 7,495 | 1,461 | 12,226 | 6,314 |
| 20-Day Average Volume | 78,585 | 2,489,755 | 1,161,558 | 11,455,267 | 7,256,401 |
| Previous Close | 16.74 | 278.76 | 467.01 | 56.80 | 88.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.72 | 309.88 | 482.04 | 55.33 | 90.78 |
| 20-Day Raw Stochastic | 4.69% | 0.00% | 9.11% | 51.68% | 10.09% |
| 20-Day Relative Strength | 39.40% | 26.02% | 44.20% | 57.26% | 49.61% |
| Weighted Alpha | -12.09 | -4.60 | +22.96 | +21.23 | +22.72 |
| Today's Opinion | 8% Buy | 40% Sell | 16% Buy | 100% Buy | 80% Buy |
| Previous Opinion | 8% Buy | 40% Sell | 32% Buy | 100% Buy | 80% Buy |
| Last Month's Opinion | 100% Buy | 8% Buy | 56% Buy | 72% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.59% since 11/11/24 | -7.51% since 11/12/24 | -5.37% since 11/12/24 | -4.10% since 11/12/24 | -6.70% since 11/12/24 |
| Low | 16.60 on 11/15/24 | 276.40 on 11/19/24 | 458.05 on 11/18/24 | 55.82 on 11/15/24 | 87.63 on 11/18/24 |
| High | 17.77 on 11/12/24 | 307.43 on 11/13/24 | 498.25 on 11/13/24 | 59.73 on 11/14/24 | 94.21 on 11/13/24 |
| 1-Month | |||||
| %Chg | -19.47% since 10/18/24 | -14.07% since 10/18/24 | -4.00% since 10/18/24 | +6.35% since 10/18/24 | +1.51% since 10/18/24 |
| Low | 16.60 on 11/15/24 | 276.40 on 11/19/24 | 458.05 on 11/18/24 | 51.81 on 10/28/24 | 85.60 on 10/22/24 |
| High | 21.50 on 10/23/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -8.88% since 08/16/24 | -15.72% since 08/19/24 | -4.99% since 08/19/24 | +14.81% since 08/19/24 | +18.24% since 08/19/24 |
| Low | 15.82 on 09/10/24 | 276.40 on 11/19/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 74.34 on 08/20/24 |
| High | 21.50 on 10/23/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -16.56% since 05/17/24 | -11.54% since 05/17/24 | +4.15% since 05/17/24 | +28.55% since 05/17/24 | +29.99% since 05/17/24 |
| Low | 15.82 on 09/10/24 | 276.40 on 11/19/24 | 435.57 on 05/30/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 21.50 on 10/23/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,933,671 | 149,842,704 | 120,268,624 | 115,200,448 | 110,244,688 |
| Shares Outstanding, K | 174,312 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 838,000,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | 100,780,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 75,806,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -61,254,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 0.85 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 07/28/21 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 07/31/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.76 | 0.00 | 48.05 | 19.95 |